Discover
CABA
Cabaletta Bio, Inc.
2.82
7 x 2.79
7 x 2.85
bid
ask
+
0.00
0.00%
175 @ 07:59 AM
2.79 -0.03 (1.06%)
| Ytd | 28.77% | |
| 1y | 71.95% |
day range
1.26
52 week range
4.23
| Open | Prev Close | 2.82 | Low | High | Mkt Cap | 459.81M | |||
| Vol | 0.00 | Avg Vol | 5.01M | EPS | -1.96 | P/E | -1.44 | Forward P/E | -0.98 |
| Beta | 3.26 | Short Ratio | 4.26 | Inst. Own | 100.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.22 | 200-d Avg | 2.85 | 1yr Est | 22.22 |
| Income Statement | |||
| Operating Expenses | 44.30M | ||
| Research and Development Expense | 37.35M | ||
| Selling, General and Administrative Expense | 6.94M | ||
| Operating Income | -44.30M | ||
| Interest Expense | 636.00K | ||
| Net Income | -43.51M | ||
| Net Income Common Stock | -43.51M | ||
| Net Income Common Stock (USD) | -43.51M | ||
| Consolidated Income | -43.51M | ||
| Earnings per Basic Share | -0.39 | ||
| Earnings per Basic Share (USD) | -0.39 | ||
| Earnings per Diluted Share | -0.39 | ||
| Earning Before Interest & Taxes (EBIT) | -42.88M | ||
| Earning Before Interest & Taxes (USD) | -42.88M | ||
| Weighted Average Shares | 112.03M | ||
| Weighted Average Shares Diluted | 112.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 116.64M | ||
| Cash and Equivalents (USD) | 116.64M | ||
| Current Assets | 122.32M | ||
| Property, Plant & Equipment Net | 20.56M | ||
| Total Assets | 148.15M | ||
| Debt Current | 23.12M | ||
| Total Debt | 26.45M | ||
| Current Liabilities | 41.51M | ||
| Debt Non-Current | 3.33M | ||
| Total Liabilities | 44.84M | ||
| Accumulated Retained Earnings (Deficit) | -560.47M | ||
| Shareholders Equity | 103.31M | ||
| Shareholders Equity (USD) | 103.31M | ||
| Assets Non-Current | 25.83M | ||
| Total Debt (USD) | 26.45M | ||
| Liabilities Non-Current | 3.33M | ||
| Trade and Non-Trade Payables | 6.38M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.34M | ||
| Net Cash Flow from Financing | 25.27M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 33.65M | ||
| Issuance (Purchase) of Equity Shares | 29.54M | ||
| Issuance (Repayment) of Debt Securities | -4.27M | ||
| Net Cash Flow from Investing | 50.96M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 50.96M | ||
| Net Cash Flow from Operations | -42.56M | ||
| Effect of Exchange Rate Changes on Cash | -13.00K | ||
| Share Based Compensation | 5.26M | ||